Position history for ARK Investment Management LLC's holdings in RECURSION PHARMACEUTICALS IN
ARK Investment Management LLC holds 37.3M shares of RXRX (RECURSION PHARMACEUTICALS IN), worth $152.6M as of 2025-Q4. The position was increased (++11.2% shares). RXRX represents 1.0% of ARK Investment Management LLC's portfolio.
Current Value
$152.6M
Current Shares
37.3M
Total Value Change
-$58.4M
Total Shares Change
+9.2M
Other major holders of RXRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BAILLIE GIFFORD & CO
Increased |
| 37.3M |
+11.2% |
| $152.6M |
| 1.0% |
| $4.11 |
53 |
| 2025-Q3 | Increased | 33.5M | +1.7% | $163.7M | 1.0% | $4.91 | 43 |
| 2025-Q2 | Decreased | 33M | -5.3% | $166.9M | 1.2% | $5.03 | 0 |
| 2025-Q1 | Increased | 34.8M | +7.6% | $184.2M | 1.8% | $5.81 | 52 |
| 2024-Q4 | Decreased | 32.3M | -1.3% | $218.7M | 1.8% | $6.77 | 0 |
| 2024-Q3 | Increased | 32.8M | +16.4% | $215.9M | 2.0% | $6.98 | 56 |
| 2024-Q2 | Increased | 28.1M | +14.5% | $211.1M | 1.9% | $7.50 | 55 |